NASDAQ:ALXO

Alx Oncology Holdings Stock Predictions

Healthcare > Biotechnology

Buy ALXO

*Your capital is at risk

$1.67

-0.110 (-6.18%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ALXO Prediction Chart

ALXO Predictions History

Latest community submissions for ALXO.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
ivan.korol91.383409	Jul 25, 2023	$17.00 +175.97% Unrealistic Excluded from avg	$5.86	X	0.00%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALXO with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ALX ONCOLOGY HOLDINGS INC.

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell c...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by